David A. Scheinberg

Affiliations: 
Weill Cornell Medical College, New York, NY, United States 
Area:
Biochemistry
Google:
"David Scheinberg"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cai W, Tanaka K, Mi X, et al. (2024) Augmenting CAR T Cell Functions with LIGHT. Cancer Immunology Research
Morales AE, Gumenick R, Genovese CM, et al. (2024) Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP. Plos Pathogens. 20: e1011881
Dao T, Xiong G, Mun SS, et al. (2023) Dual-receptor T cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML. Blood
Kurtz K, Eibler L, Dacek MM, et al. (2023) Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications. Theranostics. 13: 5469-5482
Molvi Z, Klatt MG, Dao T, et al. (2023) The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles. Journal For Immunotherapy of Cancer. 11
Mun SS, Meyerberg J, Peraro L, et al. (2023) Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1. Cancer Immunology, Immunotherapy : Cii
Malviya M, Aretz ZEH, Molvi Z, et al. (2023) Challenges and solutions for therapeutic TCR-based agents. Immunological Reviews
Bourne CM, Wallisch P, Dacek MM, et al. (2023) Host Interactions with Engineered T-cell Micropharmacies. Cancer Immunology Research
Mun SS, Peraro L, Meyerberg J, et al. (2023) Dual targeting ovarian cancer by Muc16 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1. Research Square
Bourne CM, Wallisch P, Dacek M, et al. (2023) Host-cell Interactions of Engineered T cell Micropharmacies. Biorxiv : the Preprint Server For Biology
See more...